Toxicity of hypofractionated radiotherapy and TMZ in elderly patients with glioblastoma

被引：0
|
作者：
Payano, S. [1 ]
Zapatero, J. [1 ]
de las Penas, D. [1 ]
Amaya, E. [1 ]
Samper, P. [1 ]
机构：
[1] Hosp Univ Rey Juan Carlos, Radiat Oncol, Madrid, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2022年 / 170卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1153
引用
收藏
页码：S978 / S979
页数：2
相关论文
共 50 条
  • [41] Hypofractionated Radiotherapy with Concurrent Temozolomide for Glioblastoma
    Sanghera, P.
    Tsao, M.
    Symons, S.
    Aw, L. K.
    Sahgal, A.
    Morrison, M.
    Aviv, R.
    Perry, J.
    Davey, P.
    CLINICAL ONCOLOGY, 2009, 21 (03) : 277 - 277
  • [42] Phase II Study of Bevacizumab (BEV), Temozolomide (TMZ) and Hypofractionated Stereotactic Radiotherapy (HFSRT) for Newly Diagnosed Glioblastoma (GBM)
    Beal, K.
    Omuro, A.
    Karimi, S.
    Correa, D.
    Chan, T. A.
    DeAngelis, L. M.
    Yamada, Y.
    Abrey, L. E.
    Gutin, P. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S129 - S129
  • [43] Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM).
    Omuro, A. M. P.
    Beal, K.
    Karimi, S.
    Correa, D.
    Chan, T. A.
    DeAngelis, L. M.
    Gavrilovic, I. T.
    Nolan, C.
    Hormigo, A.
    Lassman, A. B.
    Kaley, T. J.
    Mellinghoff, I. K.
    Grommes, C.
    Panageas, K.
    Reiner, A. S.
    Barradas, R.
    Abrey, L. E.
    Gutin, P. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] Utilization of Hypofractionated Radiation Therapy in Elderly Patients with Glioblastoma Multiforme
    Chu, Tiffany
    Wang, Ting
    Hooten, Ashley
    Hu, Robert
    Silberstein, Peter
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (10): : S43 - S44
  • [45] Hypofractionated Radiation Therapy For Non-Elderly Patients With Glioblastoma
    Tomasini, D.
    Triggiani, L.
    Pedretti, S.
    Bonu, M. L.
    Costa, L.
    Pegurri, L.
    Romano, L.
    Singh, N.
    Lamattina, S.
    Pastorello, E.
    Facheris, G.
    Turla, O.
    Borghetti, P.
    Bastia, M. Buglione Di Monale E.
    Magrini, S. M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S864 - S865
  • [46] ACUTE TOXICITY IN HYPOFRACTIONATED/STEREOTACTIC PROSTATE RADIOTHERAPY IN ELDERLY PATIENTS: USE OF IGRT WITH CLARITY-SYSTEM
    Di Franco, Rossella
    Borzillo, Valentina
    Alberti, Domingo
    Ametrano, Gianluca
    Petito, Angela
    Facchini, Gaetano
    Rossetti, Sabrina
    Iovane, Gelsomina
    Perdona, Sisto
    Quarto, Giuseppe
    Grimaldi, Giovanni
    Izzo, Alessandro
    Castaldo, Luigi
    Muscariello, Raffaele
    Muto, Paolo
    ANTICANCER RESEARCH, 2020, 40 (08) : 4628 - 4629
  • [47] THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Weller, Michael
    Tabatabai, Ghazaleh
    Roelcke, Ulrich
    Hottinger, Andreas
    Joerger, Francisca
    Schmid, Andrea
    Plasswilm, Ludwig
    Schrimpf, Daniel
    Mancao, Christoph
    Capper, David
    Conen, Katrin
    Hundsberger, Thomas
    Caparrotti, Francesca
    von Moos, Roger
    Riklin, Christian
    Felsberg, Joerg
    Roth, Patrick
    Jones, David
    Pfister, Stefan M.
    Rushing, Elisabeth Jane
    Abrey, Lauren
    Reifenberger, Guido
    Held, Leonhard
    von Deimling, Andreas
    Ochsenbein, Adrian
    Wirsching, Hans-Georg
    NEURO-ONCOLOGY, 2017, 19 : 2 - 2
  • [48] Should elderly patients with glioblastoma be proposed to radiotherapy?
    Lopez, S.
    Taillibert, S.
    Idbaih, A.
    Simon, J. -M.
    Mazeron, J. J.
    CANCER RADIOTHERAPIE, 2008, 12 (08): : 827 - 830
  • [49] RADIOTHERAPY plus /- TEMOZOLOMIDE IN ELDERLY PATIENTS WITH GLIOBLASTOMA
    Niyazi, M.
    Schwarz, S.
    Suchorska, B.
    Kreth, F. W.
    Tonn, J. C.
    Belka, C.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S368 - S368
  • [50] Radiotherapy with an without Temozolomide in elderly Patients with Glioblastoma
    Niyazi, M.
    Schwarz, S. B.
    Suchorska, B.
    Belka, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 88 - 88
12345